Home > Specialists > Hematology > Dr. Bing Han (韩冰)
Specialty & Clinical Focus:
Chief Physician and Professor of Hematology at Peking Union Medical College Hospital in Beijing, with a clinical focus on PNH, aplastic anemia, myelodysplastic syndromes, autoimmune hemolytic anemia and other rare blood disorders.
Professional Title & Qualifications:
-
Chief Physician,
-
Professor,
-
Doctoral Supervisor
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Hematology (Note: PUMCH is consistently ranked as the #1 hospital in China)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Bing Han (韩冰) - Hematologist
Personal Biography
Dr. Bing Han is a Chief Physician and Professor in the Department of Hematology at Peking Union Medical College Hospital (PUMCH) in Beijing. With more than 30 years of clinical experience, she leads the hospital’s Red Blood Cell Disease Group and focuses on paroxysmal nocturnal hemoglobinuria (PNH), aplastic anemia, myelodysplastic syndromes and other rare or complex hematological disorders.
She earned her M.D. and Ph.D. in Hematology from Peking Union Medical College, spent two years as a visiting scholar at the University of Washington, and completed advanced training at St. James’s University Hospital in Leeds. Her combination of long-term clinical practice, red blood cell disease expertise and international training is particularly relevant to patients seeking a specialist opinion before planning medical travel to China.
Why Choose Dr. Bing Han (and MedBridgeNZ's Role)
Dr. Bing Han’s work is centered on rare and complex hematological disorders, particularly PNH and other red blood cell diseases. She has more than 30 years of clinical experience, leads the Red Blood Cell Disease Group at PUMCH, and is the only Chinese member of the International PNH Interest Group (IPIG).
Her background is especially relevant to patients whose diagnosis, laboratory history or previous treatment course requires review by a hematologist with focused experience in PNH, aplastic anemia, myelodysplastic syndromes or autoimmune hemolytic anemia.
For an effective remote specialist review, patients should prepare a clear medical chronology, recent reports, key test results, prior treatment information and focused questions. MedBridgeNZ can coordinate this preparation, translation and submission process so the specialist office receives a structured case package before the patient decides whether to pursue an in-person pathway in Beijing.
Pre-Travel Case Review & Specialist Liaison
Before arranging travel to Beijing, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Bing Han. This pathway is particularly relevant for PNH, aplastic anemia and other conditions within her stated hematology focus when the patient wants a specialist opinion before deciding whether to pursue an in-person pathway at PUMCH.
MedBridgeNZ prepares the medical record package, coordinates translation, transfers client-authorized documents, consolidates the patient’s questions and manages communication with the relevant specialist office. Once the review request is accepted and the case package is complete, the submitted records will be reviewed by the relevant hospital specialist, who will provide an opinion, recommendations and responses to the submitted questions. MedBridgeNZ then coordinates translation and delivery of the written response and helps organize the practical next steps for travel planning.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Bing Han
Areas of Expertise
Paroxysmal Nocturnal Hemoglobinuria (PNH) – International Authority
Aplastic Anemia (AA)
Myelodysplastic Syndromes (MDS)
Autoimmune Hemolytic Anemia (AIHA)
Gaucher Disease
Thrombocytopenia
Diagnosis and management of rare hematological diseases
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 4.9/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.7/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
7,600 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Chief Physician & Professor: Department of Hematology, Peking Union Medical College Hospital (PUMCH), Beijing, China.
Visiting Scholar: University of Washington, USA (2 years).
Advanced Training Fellow: St. James's University Hospital, Leeds, UK.
Head of Group: Red Blood Cell Disease Group, PUMCH Hematology Department.
Education & Training
M.D. and Ph.D. in Hematology, Peking Union Medical College.
Visiting Scholar, University of Washington, USA (2 years).
Advanced training at St. James's University Hospital, Leeds, UK.
Awards & Honors
Academic & Professional Memberships
Member, International PNH Interest Group (IPIG).
Leader, Red Blood Cell Disease Group, Hematology Branch of the Chinese Medical Association.
Core Member of multiple national and international clinical trial groups for hematological disorders.
Research & Publications
Clinical Trials: Principal Investigator for major international and domestic multi-center trials focusing on Aplastic Anemia, MDS, and PNH treatments.
Publications: Authored numerous research papers in high-impact international journals including Blood Cancer Journal, Annals of Medicine, and British Journal of Haematology.
Global Standards: Key contributor to the formulation of international guidelines for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Selected Peer-Reviewed Publications
Selected peer-reviewed publications:
Peffault de Latour R, Röth A, Kulasekararaj AG, Han B, et al. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024;390(11):994–1008. PMID: 38477987.
Röth A, et al. Phase 3 Randomized COMMODORE 2 Trial: Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria Naive to Complement Inhibition. Am J Hematol. 2024;99(9):1768–1777. PMID: 38884175.
Liu L, Han B, et al. First-Line Treatment of Severe Aplastic Anemia: Immunosuppressive Therapy Plus Eltrombopag Versus Haploidentical Hematopoietic Stem Cell Transplantation, a Multicenter Prospective Study. Bone Marrow Transplant. 2024;59(10):1449–1457. PMID: 39090437.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Han the right specialist for my specific blood disorder?
Dr. Bing Han’s stated clinical focus includes PNH, aplastic anemia, myelodysplastic syndromes, autoimmune hemolytic anemia, Gaucher disease, thrombocytopenia and other rare hematological disorders. MedBridgeNZ can coordinate a remote specialist-review request using the patient’s medical history, recent reports, treatment chronology and focused questions. Once the request is accepted by the specialist office and the case package is complete, the submitted materials will be reviewed by the relevant hospital specialist, who will provide an opinion, recommendations and answers to the submitted questions before the patient decides whether to plan travel to Beijing.
How do I request a remote review or hospital appointment at PUMCH?
MedBridgeNZ coordinates medical-record preparation, translation, client-authorized document transfer and appointment communication with the relevant hospital office. For patients planning travel, support can also include medical invitation or visa-document coordination, travel planning, hospital navigation and non-clinical bilingual administrative assistance. Appointment dates depend on the hospital and specialist schedule, but MedBridgeNZ manages the request process, communicates required documents and keeps the patient updated. A written scope and pricing for MedBridgeNZ’s coordination service are provided before work begins.
How is communication handled if I do not speak fluent Mandarin?
MedBridgeNZ coordinates professional translation of the medical records, question list and specialist’s written response. Before the review, our bilingual team organizes the patient’s questions and confirms terminology in the submitted case package. After the hospital specialist provides an opinion, recommendations and answers, MedBridgeNZ coordinates translation and delivery to the patient. For an onsite visit in Beijing, non-clinical bilingual administrative support can also be arranged for check-in, hospital navigation and communication logistics.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We support appointment requests, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination, travel planning, hospital navigation and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment. Fees paid to MedBridgeNZ cover only the coordination services stated in writing; hospital, specialist, diagnostic, treatment and travel costs remain separate unless expressly included in a written quotation.